Renal Cancer
Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan.
December 30, 2024
Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patients.
December 30, 2024
Using three-dimensional virtual imaging of renal masses to improve prediction of robotic-assisted partial nephrectomy Tetrafecta with SPARE score.
December 27, 2024
Clinicopathologic Study of 28 Cases of Tubulocystic Renal Cell Carcinoma: Is It Time to Reclassify It as a Tubulocystic Renal Cell Tumor?
December 27, 2024
Imaging and Nonsurgical Management of Renal Masses.
December 26, 2024
Impact of race and payor status on patterns of utilization of partial and radical nephrectomy in patients with renal cell carcinoma in California.
December 26, 2024
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade.
December 26, 2024
Cytoreductive Nephrectomy Following Immunotherapy: Evolution, Pearls, and Pitfalls of Treatment.
December 25, 2024
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States.
December 23, 2024
Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial.
December 23, 2024
Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT's performance in educating patients and trainees.
December 20, 2024
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review.
December 20, 2024
Stereotactic ablative radiotherapy for primary kidney cancer - An international patterns of practice survey.
December 19, 2024
Renal cell carcinoma and macrophage research: A bibliometric analysis (2004-2023).
December 19, 2024
The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma.
December 18, 2024